9 results
Algorithm for the Evaluation of Anemia #Diagnosis #EM #IM #Honc #Anemia #Differential #Workup #Algorithm #Microcytic #Macrocytic
Algorithm for the ... Evaluation of Anemia ... #EM #IM #Honc #Anemia ... Differential #Workup #Algorithm
Evaluation of Patients with Anemia

Microcytic, Normocytic, Macrocytic, Hemolytic (Intravascular and Extravascular)

#Diagnosis #Anemia #Workup #Macrocytic #Microcytic #Normocytic
Evaluation of Patients ... with Anemia Microcytic ... #Diagnosis #Anemia ... #Differential #Algorithm
Hemolytic Anemia - Differential Diagnosis Algorithm
 • Sickle cells - Consider sickle cell disease (diverse genotypes):
Hemolytic Anemia ... Differential Diagnosis Algorithm ... diverse genotypes): SS ... ARUPLabs #Hemolytic #Anemia ... Differential #Diagnosis #Algorithm
Hematology Algorithms 

Anemia is described as a reduction in the proportion of the red blood cells.
Hematology Algorithms ... Anemia is described ... symptoms related to anemia ... often indicates IDA ... often indicates IDA
Algorithm for the evaluation of macrocytic anemia. (RBC = red blood cell; MMA = methylmalonic acid.)
Physicians
Algorithm for the ... evaluation of macrocytic ... anemia. ... elevated, but anemia ... #Homocysteine #Algorithm
Fatigue and IBD Algorithm
 • 40-50% patients have fatigue despite clinical remission
 • Risk factors: BMI,
Fatigue and IBD Algorithm ... , Anemia • Prevalence ... Crohn's > UC Anemia ... IBD Pearls: • IDA ... differentiate IDA
Evaluation of suspected incomplete Kawasaki Disease

1. AHA consensus recommendations
2. Infants ≤6 months old on day ≥7
Evaluation of suspected ... Albumin ≤3.0 g/dL, anemia ... purposes of this algorithm ... Disease #Incomplete #Algorithm
General Approach to Anemia - Differential Diagnosis Framework
1) Check reticulocyte count to determine if hypo/hyper-proliferative
2) Exclude
General Approach to Anemia ... guide further evaluation ... uw_IMresidency #anemia ... diagnosis #hematology #algorithm
Myelodysplastic syndromes current treatment algorithm 2018.

From Blood Cancer Journal, Published 24 May 2018

Myelodysplastic syndromes (MDS) are
current treatment algorithm ... risk of clonal evolution ... disease tolerate anemia ... #algorithm #hematology